| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/04/2008 | CA2687583A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity |
| 12/04/2008 | CA2687575A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity |
| 12/04/2008 | CA2687206A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 12/04/2008 | CA2686642A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 12/04/2008 | CA2667473A1 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 12/03/2008 | EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 12/03/2008 | EP1997887A1 Multimer of extracellular domain of cell surface functional molecule |
| 12/03/2008 | EP1997832A1 Monoclonal antibodies against Claudin-18 for treatment of cancer |
| 12/03/2008 | EP1997514A1 High avidity polyvalent and polyspecific reagents |
| 12/03/2008 | EP1997513A1 Photodynamic therapy for treating conditions of the eye |
| 12/03/2008 | EP1997505A1 Erythropoietin solution preparation |
| 12/03/2008 | EP1997497A2 Compositions and methods for treating a posterior segment of an eye |
| 12/03/2008 | EP1997478A2 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 12/03/2008 | EP1997477A1 Anti-acne skin agent for external use |
| 12/03/2008 | EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 12/03/2008 | EP1996700A1 Cancerous disease modifying antibody 141205-05 |
| 12/03/2008 | EP1996625A1 Anti-tat226 antibodies and immunoconjugates |
| 12/03/2008 | EP1996624A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 12/03/2008 | EP1996623A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 12/03/2008 | EP1996612A1 Compositions for treatment of cancer |
| 12/03/2008 | EP1996508A1 Water-soluble magnetic or metal oxide nanoparticles coated with ligands, preparation method and usage thereof |
| 12/03/2008 | EP1996237A2 Method for making polyethylene glycol carbonates |
| 12/03/2008 | EP1996236A2 Novel bioconjugates as therapeutic agent and synthesis thereof |
| 12/03/2008 | EP1996235A1 Polypeptides, pharmaceutical compositions and methods for the prevention and the therapeutic treatment of inflammatory disorders |
| 12/03/2008 | EP1996234A2 Nanoparticles for targeted delivery of active agents |
| 12/03/2008 | EP1996224A1 Mixtures of amylin and insulin |
| 12/03/2008 | EP1996221A2 Methods for reducing protein aggregation |
| 12/03/2008 | EP1996208A2 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| 12/03/2008 | EP1996204A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug |
| 12/03/2008 | EP1996203A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug |
| 12/03/2008 | EP1996137A2 Fluidic tissue augmentation compositions and methods |
| 12/03/2008 | EP1996118A2 Hmg co-a reductase inhibitor enhancement of bone and cartilage |
| 12/03/2008 | EP1928413A4 Hfsh aqueous formulation |
| 12/03/2008 | EP1906931B1 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof |
| 12/03/2008 | EP1906921B1 Clear pharmaceutical aqueous microemulsion comprising propofol and process for preparation |
| 12/03/2008 | EP1663165B1 Improved stearate composition and method of production thereof |
| 12/03/2008 | EP1541554B1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 12/03/2008 | EP1538980A4 Devices and methodologies useful in body aesthetics |
| 12/03/2008 | EP1397095B1 Abuse resistant opioid containing transdermal systems |
| 12/03/2008 | EP1392755B1 Lipid-polymer-conjugates compositions |
| 12/03/2008 | EP1389101B1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 12/03/2008 | EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 12/03/2008 | EP1297828B1 Oral formulations for localized colonic release and the method of preparation thereof |
| 12/03/2008 | EP1251844B1 Laxative preparation containing l-arginine |
| 12/03/2008 | EP1079804B1 Pharmaceutical compositions comprising an amphoteric surfactant an polypropoxylated cetyl alcohol and a polar drug |
| 12/03/2008 | EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/03/2008 | CN101316615A Bifunctional metal chelating conjugates |
| 12/03/2008 | CN101316614A Kit for parenteral administration of medicaments |
| 12/03/2008 | CN101316607A PDGF amphiphilic polymer complex |
| 12/03/2008 | CN101316595A Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| 12/03/2008 | CN101316593A Formulations of quinolinones |
| 12/03/2008 | CN101314644A Host-guest complex type supermolecule hollow microsphere, preparation and application thereof |
| 12/03/2008 | CN101314622A Salicylic-g-chitosan oligosaccharide grafts and synthesizing process |
| 12/03/2008 | CN101314615A Viral capsid mosaic protein HPV16 L1-P<D>, preparation method and application thereof |
| 12/03/2008 | CN101314046A Cyclodextrin inclusion method for hair orchid native |
| 12/03/2008 | CN101314045A Sulphur butyl ether-beta-cyclodextrin clathrate compound of cinnarizine, formulated product and preparation method thereof |
| 12/03/2008 | CN101314044A Oxidation resistance ligand functionalized golden nano-complexes, preparation method and application thereof |
| 12/03/2008 | CN101314043A Podophyllinic acid lactone derivant and preparation method thereof |
| 12/03/2008 | CN101314042A Water-soluble 4í»-nor-epipodophyllotoxin derivant and preparation method thereof |
| 12/03/2008 | CN101314041A Medicine carrying system of polymer micelle and preparation method thereof |
| 12/03/2008 | CN101314040A Medicine carrying material of poly ion complexes micelle, preparation and application thereof |
| 12/03/2008 | CN101314039A Biological activity glass mesoporous microsphere and preparation method thereof |
| 12/03/2008 | CN101314036A Genetic engineering polypeptide vaccine against livestock foot and mouth disease virus, and preparation method thereof |
| 12/03/2008 | CN101314034A Recombined nattokinase oral preparation, preparation method and application thereof |
| 12/03/2008 | CN101314031A Preparation for improving osteotrophy |
| 12/03/2008 | CN101314030A Preparation for accelerating bone growth |
| 12/03/2008 | CN101313989A Chinese medicinal composition for treating coronary disease, stenocardia |
| 12/03/2008 | CN101313941A Compound antihyperglycemic pellet preparation and preparation method thereof |
| 12/03/2008 | CN101313940A Traditional Chinese medicine nourishing skin-protection plaster |
| 12/03/2008 | CN101313938A Magnolia flower volatile oil spray for nose |
| 12/03/2008 | CN101313937A Chinese medicinal composition for treating influenza virus type A upper respiratory tract infection and preparation method thereof |
| 12/03/2008 | CN101313928A Southernwood oil and medicine uses of its preparations |
| 12/03/2008 | CN101313918A Medicament composition dropping pills for curing angiocardiopathy and preparation method thereof |
| 12/03/2008 | CN101313917A Chinese medicine pill |
| 12/03/2008 | CN101313916A Orally taken hypochlorous acid oxidization oral liquid |
| 12/03/2008 | CN101313914A Uses and preparations of common camptotheca fruit glycosides of common camptotheca fruit extract |
| 12/03/2008 | CN101313910A Preparation technique for sodium phosphocreatine freeze-dried injection |
| 12/03/2008 | CN101313905A Composition containing telmisartan and preparing method thereof |
| 12/03/2008 | CN101313904A Fenticonazole suppository for treating exterior colpitis |
| 12/03/2008 | CN101313903A Medicament composition containing escitalopram |
| 12/03/2008 | CN101313899A Medicament composition for eyes containing sodium bromfenac |
| 12/03/2008 | CN101313894A Freeze-dried injection of proton pump inhibitor |
| 12/03/2008 | CN101313893A Palmatine powder injection and preparation method thereof |
| 12/03/2008 | CN101313892A Glipizide calcium alginate gel rubber pellet and preparation method thereof |
| 12/03/2008 | CN100439421C Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same |
| 12/03/2008 | CN100439398C Human monoclonal antibodies to dendritic cells |
| 12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
| 12/03/2008 | CN100438925C Sanitary napkins with hydrophobic lotions |
| 12/03/2008 | CN100438917C Process for preparing micro crystal cellulose milk sugar |
| 12/03/2008 | CN100438916C Transdermal formulation hydrogel substrate and its preparing method |
| 12/03/2008 | CN100438915C Targeted nanometer medicine carrier and its prepn. method |
| 12/03/2008 | CN100438914C Tablet quickly disintegrating in oral cavity |
| 12/03/2008 | CN100438905C Stable liquid formulations of botulinum toxin |
| 12/03/2008 | CN100438880C Selenium-complement agent, and prepn. method and use thereof |
| 12/03/2008 | CN100438871C Famotidine injections |
| 12/03/2008 | CN100438869C Indometacin preparation for external use |
| 12/03/2008 | CN100438864C Eye medicine for treating fungal keratitis |
| 12/03/2008 | CN100438861C Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 12/03/2008 | CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 12/03/2008 | CN100438859C Transdermal therapeutic system (TTS) with fentanyl as active ingredient |